Atrial Fibrillation Devices Market size to exceed $12.5Bn by 2025

Atrial Fibrillation Devices Market size is set to exceed USD 12.5 billion by 2025; according to a new research study published by Global Market Insights, Inc.
 

Rising adoption rate of novel technological devices to address severe conditions of patients suffering from atrial fibrillation will stimulate the global atrial fibrillation devices business growth in the coming years. Newly advanced heart monitoring devices coupled with smartphone connectivity features to track unpredictable heart rhythm problems will enhance the market growth. Furthermore, in May 2019, Abbott launched Confirm Rx Insertable Cardiac Monitor (ICM), a new smart heart monitor used for the detection of irregular heartbeats in patients suffering from cardiac arrhythmias. It is an implantable device inserted just under the skin in the chest above the heart and provides better arrhythmia detection with utmost accuracy. Aforementioned factors will offer lucrative growth opportunities for atrial fibrillation devices market over the projected timeframe.
 

Request Sample Buy NowInquiry Before Buying

 

Growing burden of cardiovascular diseases (CVDs) such as heart stroke, angina pectoris/chest pain, cardiac arrhythmias, and congestive heart failure will positively impact atrial fibrillation devices industry growth during the forecast period. According to the Centers for Disease Control and Prevention (CDC), in the U.S., about 7,35,000 individuals are suffering from a heart attack annually. Also, heart attack is the leading cause of death for most of the people in the U.S. Thus, increasing prevalence of cardiovascular diseases (CVDs) will create significant demand for atrial fibrillation devices over forthcoming years.
 

U.S. Atrial Fibrillation Devices Market, By Product, 2018 & 2025 (USD Million)
Atrial Fibrillation Devices Market

Get more details on this report - Request Free Sample PDF
 

However, inadequate infrastructure to support atrial fibrillation techniques will restrain the demand for atrial fibrillation devices. Furthermore, the high cost associated with the application of such devices in several emerging and under-developed economies will impede the atrial fibrillation devices market growth in the forthcoming years.
 

Browse key industry insights spread across 500 pages with 805 market data tables & 30 figures & charts from the report, “Atrial Fibrillation Devices Market Size By Product (EP Ablation Catheters {Radiofrequency, Laser, Cryoablation, Ultrasound, Microwave}, EP Diagnostic Catheters {Fixed Curve Catheters, Steerable Catheters, Advanced Mapping Catheters}, Mapping and Recording Systems, Cardiac Monitors or Implantable Loop Recorder, Access Devices, Intracardiac Echocardiography, Left Atrial Appendage Closure Devices), By End-use (Hospitals, Cardiac Centers, Ambulatory Surgical Centers) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Poland, Switzerland, Belgium, Czech Republic, Netherlands, Sweden, Hungary, Austria, Portugal, Denmark, Norway, Finland, Ireland, Turkey, China, Japan, India, Australia, South Korea, Taiwan, New Zealand, Singapore, Brazil, Argentina, Venezuela, Columbia, Mexico, South Africa, Saudi Arabia, UAE, Egypt), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/atrial-fibrillation-devices-market
 

Atrial fibrillation devices market size from electrophysiology (EP) ablation catheters segment held a significant revenue size of USD  1,556.7 million in the year 2018. The high market size was attributed to its wide usage in cardiac care centers and hospitals. These catheters are useful in the treatment of abnormal cardiac rhythm, especially when medications are ineffective. It is a quick, low-risk non-invasive procedure that uses radiofrequency energy (RFR) to destroy a smaller area of heart tissue that is triggering irregular heartbeats. Furthermore, growing awareness regarding early detection and management of cardiovascular diseases (CVDs) will increase the demand for electrophysiology (EP) ablation catheters in the coming years.
 

Cardiac monitors segment is expected to grow at 14.6% during the forecast period of 2014 to 2025. Increasing acceptance of cardiac monitors among the growing population due to its superior features such as effective long-term heart rhythm monitoring capacity, efficiency, and safety as compared to standard ECG will enhance the demand for cardiac monitors in the projected timeframe. Recent technologies such as implantable cardiac monitors with smartphone connectivity feature to track the abnormal heart rhythm make these devices more prominent and appealing, thus boosting the cardiac monitors market growth in the forthcoming years.
 

Hospitals as end-use segment held majority atrial fibrillation devices market share and was valued at USD 2,483.4 million in 2018.  The high market size is attributed to growing number of multi-specialty hospitals and individual preference for hospitals over other healthcare facilities. Rising pervasiveness of cardiovascular diseases (CVDs) coupled with growing awareness about cardiac health monitoring will further enhance segmental growth. Most of the atrial fibrillation procedures are performed in highly equipped hospitals. Thus, the growing number of hospitalizations for atrial fibrillation in developed countries will accelerate segmental growth during the forecast period.
 

Cardiac centers segment is expected to grow at 15.2% during the forecast period of 2014 to 2025. Increasing adoption rate of cardiac surgery centers in developed and developing economies will stimulate the atrial fibrillation devices business growth. In these centers, cardiac operations are carried out with highly skilled professionals and quality resources such as finest equipment and facility size thus, enhancing healthcare accessibility and quality of cardiac surgery in patients suffering from various heart diseases. Aforementioned factors will drive the segmental growth in the coming years.
 

U.S. atrial fibrillation devices market share was valued at USD 2,256.7 million in the year 2018. High market size was attributed to the presence of sophisticated healthcare infrastructure and high adoption rate of advanced technologies in this country. Changes in lifestyle factors with high susceptibility to suffer from various heart diseases coupled with aging baby boomers will enhance the market growth. According to the American Heart Association (AHA), in 2019, about half of the adult population in the U.S. are suffering from some  type of cardiovascular disease. It also reported that high blood pressure (hypertension) may lead to heart attack, stroke or heart failure. Moreover, rising acceptance of advanced surgical ablation procedures for cardiac diseases monitoring will drive the U.S. atrial fibrillation device market in the forecast period.
 

India atrial fibrillation devices market is estimated to witness lucrative growth at 18.5% over the forecast period due to growing awareness about atrial fibrillation devices that are required to treat patients suffering from various cardiovascular diseases. India being the second largest populated country after China can act as a major growth driver for atrial fibrillation procedures in the country. Vast population coupled with different age groups being susceptible to cardiac diseases will escalate growth opportunities for atrial fibrillation devices. Moreover, improvement in the healthcare expenditure in developing economies including India will accelerate the market growth in the coming years.
 

Few of the major players operating in the global atrial fibrillation devices market share include Boston Scientific Corporation, CardioFocus, Inc., Hansen Medical, Johnson and Johnson (Biosense Webster) and Medtronic among other players. These industry players are involved in various strategic alliances such as collaborations, mergers & acquisitions, partnerships, and new product launches to enhance profitability and company growth. For instance, in July 2019, Boston Scientific Corporation announced that it will acquire the Cryterion Medical, a privately-held medical device company involved in developing a single-shot cryoablation platform that uses cryothermal energy for the treatment of atrial fibrillation. The acquisition would enhance the company’s atrial fibrillation ablation procedures and provides specific treatment according to the patient needs.
 

Inquiry Before BuyingRequest Sample
 

Atrial fibrillation devices market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2014 to 2025, for the following segments:

Atrial Fibrillation Devices Market by Product

  • EP Ablation Catheters
  • EP Diagnostic Catheters
  • Mapping and Recording Systems
  • Cardiac Monitors or Implantable Loop Recorder
  • Access Devices
  • Intracardiac Echocardiography (ICE)
  • Left Atrial Appendage (LAA) Closure Devices

Atrial Fibrillation Devices Industry by End-use

  • Hospitals
  • Cardiac Centers
  • Ambulatory Surgical Centers
  • Others

The above information is provided for the following regions/countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
    • Poland
    • Switzerland
    • Belgium
    • Czech Republic
    • Netherlands
    • Sweden
    • Hungary
    • Austria
    • Portugal
    • Denmark
    • Norway
    • Finland
    • Ireland
    • Turkey
    • Greece
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Taiwan
    • New Zealand
    • Singapore
  • Latin America
    • Brazil
    • Argentina
    • Venezuela
    • Columbia
    • Mexico
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X